Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.
Open accessThe DOI matches its Crossref record.
Abstract
To identify and measure the incidence of adverse effects of the angiotensin converting enzyme inhibitor enalapril 13,713 patients were studied for one year by prescription-event monitoring. Precise information about the duration of treatment was available for 12,543 patients. The frequency of many events was calculated, including dizziness (483 patients; 3.9%), persistent dry cough (360; 2.9%), headache (310; 2.5%) hypotension (218; 1.7%), and syncope (155; 1.2%). Less common reactions included angioedema, urticaria, and muscle cramps. Altogether 1098 (8%) patients died and the notes of 913 of them (83%) were obtained for detailed scrutiny. With the exception of a few patients with renal failure who deteriorated during treatment (reported on separately), no death was attributed to enalapril. Enalapril was considered to be effective, even in patients with advanced cardiac failure. These results for enalapril are reassuring and provide further evidence of the value of prescription-event monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910
Hereditary Angioedema: A Broad Review for Clinicians
Nzeako, U. C. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.20.2417 · Cited by 336
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90161-7 · Cited by 313
ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management
Vleeming, W., van Amsterdam, J. G. C., Stricker, B. H., & de Wildt, D. J. (1998) · Drug Safety · doi:10.2165/00002018-199818030-00003 · Cited by 243
“2% among the Caucasian population,[7-9] whereas a higher incidence has been reported for Black Americans.”
BackgroundACE Inhibitor???Induced Cough and Bronchospasm: Incidence, Mechanisms and Management
Overlack, A. (1996) · Drug Safety · doi:10.2165/00002018-199615010-00006 · Cited by 114
Metadata
- Authors
- Inman, W. H., Rawson, N. S., Wilton, L. V., Pearce, G. L., & Speirs, C. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1988-10-01
- Volume
- 297
- Issue
- 6652
- Pages
- 826-829
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2092170492
- Cited by
- 112
- References
- 0
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. https://app.cochat.ai/papers/10.1136/bmj.297.6652.826
- The paper
- Inman, W. H., Rawson, N. S., Wilton, L. V., Pearce, G. L., & Speirs, C. J. (1988). Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ. https://doi.org/10.1136/bmj.297.6652.826
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.